Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Urbinati

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Antimicrobial Agents and Chemotherapy|April 25, 2007
Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of human immunodeficiency virus type 1 Tat and gp120 proteinsAntonella Bugatti, Chiara Urbinati, Cosetta Ravelli, et al.
The Journal of Biological Chemistry|December 20, 2021
The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanismsGiulia Paiardi, Stefan Richter, Pasqua Oreste, et al.
Oncogene|May 29, 2002
Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contactsElena Tanghetti, Roberto Ria, Patrizia Dell'Era, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2005
Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokineStefania Mitola, Mirella Belleri, Chiara Urbinati, et al.
Molecules (Basel, Switzerland)|December 24, 2021
HIV-1 Tat and Heparan Sulfate Proteoglycans Orchestrate the Setup of <i>in Cis</i> and <i>in Trans</i> Cell-Surface Interactions Functional to Lymphocyte Trans-Endothelial MigrationChiara Urbinati, Maria Milanesi, Nicola Lauro, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 25, 2012
Substrate-immobilized HIV-1 Tat drives VEGFR2/α(v)β(3)-integrin complex formation and polarization in endothelial cellsChiara Urbinati, Cosetta Ravelli, Elena Tanghetti, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 17, 2005
Integrin alphavbeta3 as a target for blocking HIV-1 Tat-induced endothelial cell activation in vitro and angiogenesis in vivoChiara Urbinati, Stefania Mitola, Elena Tanghetti, et al.
FEBS Letters|June 16, 2004
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonistsChiara Urbinati, Antonella Bugatti, Pasqua Oreste, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2005
Cutting edge: proangiogenic properties of alternatively activated dendritic cellsElena Riboldi, Tiziana Musso, Emanuela Moroni, et al.
International Journal of Molecular Sciences|April 5, 2020
Recent Strategic Advances in CFTR Drug Discovery: An OverviewMarco Rusnati, Pasqualina D'Ursi, Nicoletta Pedemonte, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Antimicrobial Agents and Chemotherapy|April 25, 2007
Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of human immunodeficiency virus type 1 Tat and gp120 proteinsAntonella Bugatti, Chiara Urbinati, Cosetta Ravelli, et al.
The Journal of Biological Chemistry|December 20, 2021
The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanismsGiulia Paiardi, Stefan Richter, Pasqua Oreste, et al.
Oncogene|May 29, 2002
Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contactsElena Tanghetti, Roberto Ria, Patrizia Dell'Era, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2005
Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokineStefania Mitola, Mirella Belleri, Chiara Urbinati, et al.
Molecules (Basel, Switzerland)|December 24, 2021
HIV-1 Tat and Heparan Sulfate Proteoglycans Orchestrate the Setup of <i>in Cis</i> and <i>in Trans</i> Cell-Surface Interactions Functional to Lymphocyte Trans-Endothelial MigrationChiara Urbinati, Maria Milanesi, Nicola Lauro, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 25, 2012
Substrate-immobilized HIV-1 Tat drives VEGFR2/α(v)β(3)-integrin complex formation and polarization in endothelial cellsChiara Urbinati, Cosetta Ravelli, Elena Tanghetti, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 17, 2005
Integrin alphavbeta3 as a target for blocking HIV-1 Tat-induced endothelial cell activation in vitro and angiogenesis in vivoChiara Urbinati, Stefania Mitola, Elena Tanghetti, et al.
FEBS Letters|June 16, 2004
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonistsChiara Urbinati, Antonella Bugatti, Pasqua Oreste, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2005
Cutting edge: proangiogenic properties of alternatively activated dendritic cellsElena Riboldi, Tiziana Musso, Emanuela Moroni, et al.
International Journal of Molecular Sciences|April 5, 2020
Recent Strategic Advances in CFTR Drug Discovery: An OverviewMarco Rusnati, Pasqualina D'Ursi, Nicoletta Pedemonte, et al.
Pageof 5